| SANDOZ GROUP AG SF -,05 |
| Schweiz |
| Gesundheit |
| CH1243598427 / A3ETYB |
| D8Y (Frankfurt) |
| FRA:D8Y, ETR:D8Y, D8Y:GR |
| SMI |
| https://www.sandoz.com/ |
|
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patien..
>Volltext.. |
| 38594.22 Mio. EUR |
| 42928.56 Mio. EUR |
| 10176.34 Mio. EUR |
| 2064 Mio. EUR |
| 568.99 Mio. EUR |
| 1.31 EUR |
| 5525.66 Mio. EUR |
| 1113.51 Mio. EUR |
| 1666.72 Mio. EUR |
| 0.15 |
| 2.06% |
| 168.52% |
| 0.87 EUR |
| 0.99% |
| 1% |
| 13.04.26 - 0.8673081€ |
| - |
| SANDOZ |
| 28.10.26 |
|
||||
|
||||
|
||||
|
||||
|